Videos

In an interview with Pharma Commerce Associate Editor Don Tracy, John Hoffman, Principal, Advocate for Success, LLC talks about his 'Health Equity Spotlight' panel and advocacy accomplishments.

In this Pharmaceutical Commerce video interview, Joerg Tritschler, a partner in Simon-Kucher’s life sciences division, talks about the challenging environment today for emerging biopharma companies in demonstrating the value of their promising early-stage drug candidates to potential investors or buyers.

In this Pharmaceutical Commerce video interview, Joerg Tritschler, a partner in Simon-Kucher’s life sciences division, discusses the positive signs from rising activity levels in biopharma M&A— and what the momentum may mean for industry dealmaking and partnership efforts in the months ahead.

In this Pharmaceutical Commerce video interview, Emma Banks, CEO of ramarketing, talks about what emerging scientific advancements will have the biggest impact on the future direction of the biotechnology industry.

In this Pharmaceutical Commerce video interview, Emma Banks, CEO of ramarketing, discusses the biggest roadblocks to the widespread adoption of novel modalities, and how new biotech companies can navigate the current funding slowdown while securing the capital crucial for their success.

In this Pharmaceutical Commerce video interview, Emma Banks, CEO of ramarketing, discusses how the balance between onshoring and outsourcing will evolve, how long will the current slowdown in biotech investment likely last, and what factors might influence its duration.

In an interview with Pharma Commerce Associate Editor Don Tracy, Corey Ford, VP, Reimbursement, Policy Insights, Cencora, provides a look at his recent webinar focused on the implications of the Inflation Reduction Act.

In an interview with Pharma Commerce associate editor Don Tracy, Lynn Kirkpatrick, PhD, CEO, Ensysce Biosciences, discusses the FDA's Breakthrough Therapy Designation for PF614-MPAR, which focuses on protecting patients from drug overdoses.

In an interview with Pharma Commerce Associate Editor Don Tracy, Ron Lanton, Partner, Lanton Law PLLC, discusses recent moves by CVS and Express Scripts to follow Mark Cuban's drug plus model.

Partner for Archbow Consulting discusses the conference, the IRA, and specifics of PAP business rules

Bill Trombetta, PhD, discusses successfully navigating what he calls “the coming perfect storm” in healthcare.

Bayer executive talks Enable Holistic Hub and Provider Services panel.

Founding Partner of Curatio Scientia speaks on her upcoming panel at Trade & Channel Strategies 2023.

Lexicon Pharmaceuticals exec discusses upcoming Enable Holistic Hub and Provider Services panel.

Blue Fin Group exec speaks on his upcoming feature.

Blue Fin Group executive highlights how leaders can plan for immediate profitable lifecycles and beyond.

SVP and Managing Director for Blue Fin Group offers a synopsis of the conference opener.

Director of Berkeley Research Group explains changes to 340B moving forward.

Berkeley Research Group executive speaks about the role of manufacturers in 340B pricing.

Berkeley Research Group Director discusses what to expect at his upcoming session.

Direct Relief executive provides more information about the company.

Jenifer Smith talks about what to expect during breakout session.

Jenifer Smith provides suggestions on what can be done to continue growth and development.

Direct Relief executive offers her thoughts on breakout session.

Tracy Nasarenko offers her final thoughts on DSCSA implementation guidelines at LogiPharma USA 2023.

Sr. Director of Community Engagement for Pharmaceuticals at GS1 US explains what the implementation guidelines are meant to accomplish.

GS1 US Executive provides insight on how pharma supply can speed up the process of complying with regulations.

In an interview at LogiPharma USA 2023 with Pharma Commerce Editor Nicholas Saraceno, Tracy Nasarenko, Sr. Director of Community Engagement for Pharmaceuticals, GS1 US highlights her “DSCSA—Final Checks to Have Before Deadlines.”

In an interview at the DIA Global Annual Meeting with Pharma Commerce Editor, Nicholas Saraceno, Venkatraman Balasubramanian discusses broader supply chain issues.

In an interview with Pharma Commerce Editor, Nicholas Saraceno, Courtney Granville, Director, Scientific Affairs, Drug Information Association, discusses issues impacting broader supply chains.